Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer-Reference-Cited by-同舟云学术

Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer

Published:2021-07 Issue:1 Volume:206 Page:69-79
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Wenzel Mike¹²,Nocera Luigi²³,Collà Ruvolo Claudia²⁴,Würnschimmel Christoph²⁵,Tian Zhe²,Shariat Shahrokh F.⁶⁷⁸⁹¹⁰,Saad Fred²,Briganti Alberto³,Tilki Derya⁵,Graefen Markus⁵,Kluth Luis A.¹,Mandel Philipp¹,Chun Felix K. H.¹,Karakiewicz Pierre I.²

Affiliation:

1. Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany

2. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada

3. Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy

4. Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Italy

5. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany

6. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

7. Departments of Urology, Weill Cornell Medical College, New York, New York

8. Department of Urology, University of Texas Southwestern, Dallas, Texas

9. Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic

10. Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma Patients;Journal of Racial and Ethnic Health Disparities;2024-08-19

2. Aktueller Behandlungsstandard und Trends der Systemtherapie beim metastasierten hormonsensiblen Prostatakarzinom – Anwendung der Studiendaten in der Praxis;Die Urologie;2024-08-14

3. Other‐cause mortality in incidental prostate cancer;The Prostate;2024-03-20

4. Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study;Cancer Causes & Control;2023-11-25

5. Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center;Medicina;2023-03-21